Rungmaitree, S.; Thepthai, C.; Toh, Z.Q.; Musiwiraphat, N.; Maleesatharn, A.; Rermruay, R.; Sungkate, S.; Phongsamart, W.; Lapphra, K.; Wittawatmongkol, O.;
et al. Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines 2022, 10, 118.
https://doi.org/10.3390/vaccines10010118
AMA Style
Rungmaitree S, Thepthai C, Toh ZQ, Musiwiraphat N, Maleesatharn A, Rermruay R, Sungkate S, Phongsamart W, Lapphra K, Wittawatmongkol O,
et al. Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines. 2022; 10(1):118.
https://doi.org/10.3390/vaccines10010118
Chicago/Turabian Style
Rungmaitree, Supattra, Charin Thepthai, Zheng Quan Toh, Noppasit Musiwiraphat, Alan Maleesatharn, Rattanachai Rermruay, Sathida Sungkate, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol,
and et al. 2022. "Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution" Vaccines 10, no. 1: 118.
https://doi.org/10.3390/vaccines10010118
APA Style
Rungmaitree, S., Thepthai, C., Toh, Z. Q., Musiwiraphat, N., Maleesatharn, A., Rermruay, R., Sungkate, S., Phongsamart, W., Lapphra, K., Wittawatmongkol, O., Dharakul, T., Mulholland, K., & Chokephaibulkit, K.
(2022). Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines, 10(1), 118.
https://doi.org/10.3390/vaccines10010118
